Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
Status:
Recruiting
Trial end date:
2022-11-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Apixaban, Warfarin and Aspirin
Anticoagulation are effective and safe in Prevention of Portal Vein Thrombosis in Liver
Cirrhotic Patients after Laparoscopic Splenectomy